Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia
about
Occurrence of Epstein-Barr virus-associated plasmacytic lymphoproliferative disorder after antithymocyte globulin therapy for aplastic anemia: a case report with review of the literatureTargeting of natural killer cells by rabbit antithymocyte globulin and campath-1H: similar effects independent of specificityEpstein-Barr Virus-associated Lymphoproliferative Disorder with Encephalitis Following Anti-thymocyte Globulin for Aplastic Anemia Resolved with Rituximab Therapy: A Case Report and Literature ReviewHorse antithymocyte globulin as salvage therapy after rabbit antithymocyte globulin for severe aplastic anemia.Less graft-versus-host disease after rabbit antithymocyte globulin conditioning in unrelated bone marrow transplantation for leukemia and myelodysplasia: comparison with matched related bone marrow transplantationAlemtuzumab treatment of intermediate-1 myelodysplasia patients is associated with sustained improvement in blood counts and cytogenetic remissions.Epstein-barr virus related lymphoproliferations after stem cell transplantation.Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia.Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemiaAnti-thymocyte globulin could improve the outcome of allogeneic hematopoietic stem cell transplantation in patients with highly aggressive T-cell tumorsGraves disease following rabbit antithymocyte globulin treatment of severe aplastic anemia in a Korean child.In vivo effects of horse and rabbit antithymocyte globulin in patients with severe aplastic anemia.Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic AAlemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 studyCytomegalovirus positive ulcerative colitis: A single center experience and literature review.Horse versus rabbit antithymocyte globulin in acquired aplastic anemiaThe transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donor.Pancytopenia secondary to cytomegalovirus reactivation.Final results of the phase II study of rabbit anti-thymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony-stimulating factor in patients with aplastic anaemia and myelodysplastic syndromeComparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood.Long-term outcome after immunosuppressive therapy with horse or rabbit antithymocyte globulin and cyclosporine for severe aplastic anemia in children.Epstein-Barr virus-related lymphoproliferative disorder induced by equine anti-thymocyte globulin therapy.The Third Consensus Conference on the treatment of aplastic anemia.Concise review: Anemia caused by viruses.An Epstein-Barr virus-associated leukemic lymphoma in a patient treated with rabbit antithymocyte globulin and cyclosporine for hepatitis-associated aplastic anemia.Alternative immunosuppression in patients failing immunosuppression with ATG who are not transplant candidates: Campath (Alemtuzumab).Current management of severe acquired aplastic anemia.Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia.Efficacy of combination therapy with anti-thymocyte globulin and cyclosporine A as a first-line treatment in adult patients with aplastic anemia: a comparison of rabbit and horse formulations.Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia.Fatal Epstein-Barr Virus Reactivation in an Acquired Aplastic Anemia Patient Treated with Rabbit Antithymocyte Globulin and Cyclosporine A.Prevalence and clinical outcomes of hepatitis B virus infection in patients with aplastic anemia.Ileal mass-like lesion induced by Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in a patient with aplastic anemia.Severe Colitis Associated with both Epstein-Barr Virus and Cytomegalovirus Reactivation in a Patient with Severe Aplastic Anemia.Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia.B-Cell-Rich T-Cell Lymphoma Associated with Epstein-Barr Virus-Reactivation and T-Cell Suppression Following Antithymocyte Globulin Therapy in a Patient with Severe Aplastic AnemiaRabbit antithymocyte globulin versus horse antithymocyte globulin for treatment of acquired aplastic anemia: a retrospective analysis.Hepatitis B in renal transplant patients.Colonic EBV-Associated Lymphoproliferative Disorder in a Patient Treated with Rabbit Antithymocyte Globulin for Aplastic Anemia.Antithymocyte globulin and transplants for aplastic anemia
P2860
Q26859969-5B464A5D-7DDC-47E9-94F5-50472D2CE55CQ33415472-8BD02A38-C590-4724-85A5-7247F239C824Q33619215-CC7C7D61-8DB6-4EEA-8B07-D57BBDD5279AQ33757965-78F04A41-583C-4254-BC86-9DCCBEA362ACQ34134601-F011C82C-F32C-4242-B79A-AE3C49E0B843Q34488656-69CED5F6-64ED-4DC0-948B-4575236E7F36Q34549457-27B2B6C0-A633-4A0A-A680-FCD25E74FEC6Q35193715-4409D8A3-27E7-41B0-BB49-709D0AEA21A0Q35669193-568AA7D4-F7E8-42E7-A7AE-925925FDD8F9Q35921888-8423BE91-06C9-4CF7-8F4F-5873710F411EQ35976451-AA6086BA-0F2D-4BCB-A4C6-DBD1ECB216DFQ36036288-96690BC0-BD8E-45A4-8639-7D6483CAD85EQ36464652-8B2644D2-5997-4804-A04F-3EE713B7B336Q36486302-B54F2D65-B079-4F8A-98CB-53792413363FQ36769057-D562E774-BF0C-4915-8A74-2B9C5FFD6A52Q37040881-E7E09F6B-B5A9-4B27-B08F-AEBC2571B21DQ37460362-DB5CDB13-B2B8-40F4-AF2A-D0EA4DF8FCFAQ37517212-2804DBE8-4398-41FA-9492-2201F1CCB080Q37584833-92B80320-7A34-4857-A0E0-E0738CD9B807Q37676271-C10AEF94-3471-488D-8BD6-822A3F18CDB5Q37676274-76643DCA-B8DC-44E9-8709-89FF3B8E3905Q37777360-28F5EF60-49D2-4257-9A31-CD54DD660EADQ37880645-45FA5381-CF81-4D61-8EAE-BEEF46699035Q37928594-5DFF6692-6C60-4FAD-AF91-EB47C41601CCQ37969523-11C68F87-5F87-4D92-8D7A-DE1548789DC8Q38065877-5962611E-F8F4-453E-BFF4-45623EB87EEBQ38694686-4B903D1E-1B1E-4588-8A00-85EC30D17D4FQ38877341-20330DCB-F271-437B-8F2C-0E131D1CEDA4Q39659581-BA7321EE-1C77-4605-9BD0-41C39AFEDEC5Q40090645-79DAC8C6-EBC4-4F50-994C-7C81EDBE38A0Q40136894-30C7ABF9-C2B3-4ABB-A0BB-C6B5F91D5818Q40160942-FB42B999-94BE-4A47-A67C-C940556274A0Q40190104-5C41DC65-B0AE-4132-B271-6440E851CC8EQ40196900-0235F191-ED7E-4F00-BABD-EE1CC5E5B5B1Q40384599-3C7C91C6-77D1-43BC-8E39-B3D3FCF5D935Q40942804-1A572DFF-3585-477B-8FEF-3D4A81C24EA0Q41489617-3991FD0C-24F1-4521-832B-B74EB059B890Q41690591-155903F4-AE1E-4CCA-893F-90F3592854C2Q41814460-19DBD2F2-AE62-48D5-9163-5E1241339EA6Q42348449-67939EFB-1C89-47AA-919B-6B655B8BD311
P2860
Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Distinct EBV and CMV reactivat ...... ts with severe aplastic anemia
@ast
Distinct EBV and CMV reactivat ...... ts with severe aplastic anemia
@en
type
label
Distinct EBV and CMV reactivat ...... ts with severe aplastic anemia
@ast
Distinct EBV and CMV reactivat ...... ts with severe aplastic anemia
@en
prefLabel
Distinct EBV and CMV reactivat ...... ts with severe aplastic anemia
@ast
Distinct EBV and CMV reactivat ...... ts with severe aplastic anemia
@en
P2093
P2860
P1433
P1476
Distinct EBV and CMV reactivat ...... ts with severe aplastic anemia
@en
P2093
A John Barrett
Colin O Wu
Elaine M Sloand
Jeffrey I Cohen
Neal S Young
Olga Nunez
Steven H Fischer
P2860
P304
P356
10.1182/BLOOD-2006-09-045625
P407
P577
2006-12-05T00:00:00Z